Adverum Biotechnologies, Inc.

NASDAQ:ADVM

7.72 (USD) • At close November 5, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

202320222021202020192018201720162015201420132012
Assets:
Current Assets:
Cash & Cash Equivalents 7568.43134.19562.42465.897154.94970.519222.17259.08159.4040.5640.357
Short Term Investments 21.526117.158270.993367.305100.13850.13119.966037.732000
Cash and Short Term Investments 96.526185.589305.188429.729166.035205.079190.485222.17259.08159.4040.5640.357
Net Receivables 005.70900000.8860.44900.0080.001
Inventory 000000000000
Other Current Assets 6.2475.0066.2484.7099.8353.6753.2562.2181.4630.8740.250.024
Total Current Assets 102.773190.595317.145434.438175.87208.754193.741225.274260.992160.2780.8220.382
Non-Current Assets:
Property, Plant & Equipment, Net 67.03113.861119.0647.10145.8473.5863.0244.1693.1871.0850.0690.004
Goodwill 000000000000
Intangible Assets 000000550000
Goodwill and Intangible Assets 000000550000
Long Term Investments 1.9762.5033.2720.9990.9990.999000000
Tax Assets 000000000000
Other Non-Current Assets 1.2311.4130.250.0290.0110.1560.140.140.140.5430.1940
Total Non-Current Assets 70.237117.777122.58248.12946.8574.7418.1649.3093.3271.6280.2630.004
Total Assets 173.01308.372439.727482.567222.727213.495201.905234.583264.319161.9061.0850.386
Liabilities & Equity:
Current Liabilities:
Account Payables 1.9212.2381.3872.814.1031.7071.7311.4740.6050.9510.7690.522
Short Term Debt 10.40913.2411.8864.4734.0340.16.8486.5474.0733.68700
Tax Payables 0.1010.2541.3180.0400000000
Deferred Revenue 0.101016.0312.2638.635-0.11.851.850.8830.81300
Other Current Liabilities 12.48316.7672.0171.3252.6369.0120.2450.0251.0130.020.3930.317
Total Current Liabilities 24.91432.24621.3220.87119.40810.71910.6749.8966.5745.4711.1620.839
Non-Current Liabilities:
Long Term Debt 64.62793.561101.10826.23528.2140.20.2220.3520000.485
Deferred Revenue Non-Current 0000005.257.0994.7066.64600
Deferred Tax Liabilities Non-Current 0000001.251.250000
Other Non-Current Liabilities -01.0471.1141.1140.1481.4090.4810.3860.4470.3060.1410.059
Total Non-Current Liabilities 64.62794.608102.22227.34928.3621.6097.2039.0875.1536.9520.1410.544
Total Liabilities 89.541126.854123.54248.2247.7712.32817.87718.98311.72712.4231.3031.383
Equity:
Preferred Stock 000000000161.9067.9922.471
Common Stock 0.010.010.010.010.0070.0060.0050.0040.0030.00200
Retained Earnings -919.777-802.612-648.076-502.536-385.029-320.543-254.062-197.915-84.168-36.715-8.869-3.593
Accumulated Other Comprehensive Income/Loss -0.473-1.531-0.714-0.261-0.725-0.799-0.963-0.007-0.0110.010.0270.008
Other Total Stockholders Equity 1,003.709985.651964.965937.134560.704522.503439.048413.518336.76824.280.6320.117
Total Shareholders Equity 83.469181.518316.185434.347174.957201.167184.028215.6252.592149.483-0.218-0.997
Total Equity 83.469181.518316.185434.347174.957201.167184.028215.6252.592149.483-0.218-0.997
Total Liabilities & Shareholders Equity 173.01308.372439.727482.567222.727213.495201.905234.583264.319161.9061.0850.386